Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

BMO Capital Maintains Outperform on Constellium, Raises Price Target to $25

Author: Benzinga Newsdesk | December 04, 2023 09:43am
BMO Capital analyst Katja Jancic maintains Constellium (NYSE:CSTM) with a Outperform and raises the price target from $22 to $25.

Posted In: CSTM

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist